DECITABINE
Generic: DECITABINE
BluePoint LaboratoriesManufacturer
INTRAVENOUSRoute
DECITABINEActive Substance
2019-09-16Original Approval
DECITABINE is FDA application ANDA210984, sponsored by INGENUS PHARMS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
501 reports
2
FEBRILE NEUTROPENIA
455 reports
3
MYELOSUPPRESSION
372 reports
4
DRUG INEFFECTIVE
340 reports
5
PNEUMONIA
319 reports
6
NEUTROPENIA
287 reports
7
DEATH
284 reports
8
PYREXIA
260 reports
9
ACUTE MYELOID LEUKAEMIA
240 reports
10
THROMBOCYTOPENIA
240 reports